GIOTRIF® : The 1st choice in 1st-line

Hypertensive Care

beyond Blood Pressure Control
 
 

Boehringer Ingelheim’s Telmisartan is the ONLY ARB that is INDICATED* to reduce both CV morbidity and mortality for high-risk patients

Document ID: PC-PH-104646

13/04/2023

Author: Boehringer Ingelheim


Telmi OPD Video 2_Azhari Rosman_Anti-HPN for High CV risk patients

Related content

 
PC-PH-104646
Production date: Apr 2023